Home/Companies/Pharma/CEVA Santé Animale

CEVA Santé Animale

France·Active·1yr hold

Entry

2025

Hold

1yr

Status

Active

Who owns CEVA Santé Animale?

CEVA Santé Animale is currently owned by Merieux Equity Partners through Mérieux Participations 4 (2023 vintage), since 2025. Across its history, CEVA Santé Animale has been through 11 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Most recent investor

Merieux Equity Partners

Mérieux Participations 4 · 2023 · Buyout

15 ownership periods · full history below

Key facts

HQFrance

SectorPharma

Websitewww.ceva-santeanimale.fr

Key takeaways

·Co-held by Sagard, Grand Sud-Ouest Capital, EMZ Partners, Societe Generale Capital Partenaires, Irdi Capital-Investissement, NiXEN and Merieux Equity Partners since 2010.
·Average hold across 6 realized cycles: 8 years.
·11 distinct PE sponsors across ownership cycles.

Ownership history

14 ownership periods · co-invest detected · 1 lender on file

Active

Co-held by Sagard, Grand Sud-Ouest Capital, EMZ Partners, Societe Generale Capital Partenaires, Irdi Capital-Investissement, NiXEN and Merieux Equity Partners since 2010.

Co-invest · 13 holders · 1 lender · 1999 · present

Irdi Capital-InvestissementExited 2014

1999 · 2014(15yr) · IRDI Capital Croissance · 1996 · Growth

Secondary

MOIC

–

EMZ PartnersExited 2014

1999 · 2014(15yr) · EMZ Legacy · 2005

Secondary · to

MOIC

–

PAI PartnersExited 2003

1999 · 2003(4yr) · PAI LBO Fund · 1998 · Buyout

Secondary · to

MOIC

–

IK PartnersExited 2007

2003 · 2007(4yr) · IK 2000 · 2000 · Buyout

MBO · to

MOIC

–

NiXENExited 2014

2007 · 2014(7yr) · NiXEN I · 2005 · Buyout

Secondary · to

MOIC

–

Aquiti GestionExited 2014

2010 · 2014(4yr) · NACI 1 · 2018 · Growth

MBO · to

MOIC

–

SagardActive

2010 · present(16yr) · Sagard · 2002 · Buyout

Grand Sud-Ouest CapitalActive

2014 · present(12yr) · Grand Sud Ouest Capital · 1991 · Buyout

EMZ PartnersActive

2020 · present(6yr) · EMZ 9 · 2020

CIC Private DebtLender

2022 · present(4yr) · CIC Debt Fund 4 · 2022 · Private Debt

Merieux Equity PartnersActive

2025 · present(1yr) · Mérieux Participations 4 · 2023 · Buyout

NiXENActive

2025 · present(1yr) · NiXEN II · 2012 · Buyout

Irdi Capital-InvestissementActive

2025 · present(1yr) · IRDI Capital Croissance · 1996 · Growth

Societe Generale Capital PartenairesActive

2025 · present(1yr) · SGCP Evergreen (balance sheet) · 1991 · Evergreen

iXO Private EquityExited 2025

exited 2025 · IXO 3 · 2015 · Growth

Secondary · to

MOIC

–

More from Mérieux Participations 4

Other portfolio companies in the same fund.

More Merieux Equity Partners portfolio companies

From the same investor, across funds.

Ceva Sante Animale

Ona Therapeutics

Curea Medical GmbH

Prothea Technologies

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health

CVC Capital Partners

General AtlanticChina

iXO Private Equity

The Carlyle Group

Ideal Cures Pvt. Ltd.

TA AssociatesIndia

Track Ceva

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Ceva?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Ceva.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment

Save this company to your watchlist

Exit buyers and MOIC on realized deals (Pro)

or

Continue with email

Already a member? Sign in

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue